Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)

ABSTRACT: A phase II trial was launched to evaluate if neoadjuvant stereotactic ablative radiotherapy (SABR) before surgery improves oncologic outcomes in patients with stage I non-small cell lung cancer (NSCLC). We report a mandated interim safety analysis for the first 10 patients who completed pr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Radiat Oncol
Auteurs principaux: Palma, David A., Nguyen, Timothy K., Kwan, Keith, Gaede, Stewart, Landis, Mark, Malthaner, Richard, Fortin, Dalilah, Louie, Alexander V., Frechette, Eric, Rodrigues, George B., Yaremko, Brian, Yu, Edward, Dar, A. Rashid, Lee, Ting-Yim, Gratton, Al, Warner, Andrew, Ward, Aaron, Inculet, Richard
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Short Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5270342/
https://ncbi.nlm.nih.gov/pubmed/28129789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0770-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires